A Benefit-Risk Review of Systemic Haemostatic Agents Ian S. FraserRobert J PorteAndrea S. Lukes Review Article 19 October 2012 Pages: 275 - 282
Dysglycaemias and Fluoroquinolones Roshan J. LewisJohn F. Mohr III Review Article 19 October 2012 Pages: 283 - 292
Propofol Infusion Syndrome Vincenzo FodaleEnza La Monaca Review Article 19 October 2012 Pages: 293 - 303
Adequacy of Patient Information on Adverse Effects Neil CarriganD. K. RaynorPeter Knapp Short Communication 19 October 2012 Pages: 305 - 312
Safety Profile of Esomeprazole Miranda DaviesLynda V. WiltonSaad A. W. Shakir Original Research Article 19 October 2012 Pages: 313 - 323
Hepatic Effects of Lovastatin Exposure in Patients with Liver Disease Andrew L. AvinsMichele M. ManosJeffrey G. Levine Original Research Article 19 October 2012 Pages: 325 - 334
Improving the Reporting of Adverse Drug Reactions Maria T. HerdeiroJorge PolóniaAdolfo Figueiras Original Research Article 19 October 2012 Pages: 335 - 344
Hepatic Events Associated with Atomoxetine Treatment for Attention-Deficit Hyperactivity Disorder Mark E. BangsLing JinJoachim F. Wernicke Original Research Article 19 October 2012 Pages: 345 - 354
Publishing Histories of Adverse Reactions to Medicaments Anecdotally Jeffrey K. Aronson Correspondence 19 October 2012 Pages: 355 - 356
The Authors’ Reply William KellyNicholas MooreEugene van Puijenbroek Correspondence 19 October 2012 Pages: 356 - 357